These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37817331)

  • 21. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
    J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-based design of bitopic ligands for the µ-opioid receptor.
    Faouzi A; Wang H; Zaidi SA; DiBerto JF; Che T; Qu Q; Robertson MJ; Madasu MK; El Daibani A; Varga BR; Zhang T; Ruiz C; Liu S; Xu J; Appourchaux K; Slocum ST; Eans SO; Cameron MD; Al-Hasani R; Pan YX; Roth BL; McLaughlin JP; Skiniotis G; Katritch V; Kobilka BK; Majumdar S
    Nature; 2023 Jan; 613(7945):767-774. PubMed ID: 36450356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-Based Approach for the Prediction of Mu-opioid Binding Affinity of Unclassified Designer Fentanyl-Like Molecules.
    Floresta G; Rescifina A; Abbate V
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31083294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delineating the Ligand-Receptor Interactions That Lead to Biased Signaling at the μ-Opioid Receptor.
    Kelly B; Hollingsworth SA; Blakemore DC; Owen RM; Storer RI; Swain NA; Aydin D; Torella R; Warmus JS; Dror RO
    J Chem Inf Model; 2021 Jul; 61(7):3696-3707. PubMed ID: 34251810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Homology models of mu-opioid receptor with organic and inorganic cations at conserved aspartates in the second and third transmembrane domains.
    Zhorov BS; Ananthanarayanan VS
    Arch Biochem Biophys; 2000 Mar; 375(1):31-49. PubMed ID: 10683246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness for the combination of G-protein- and β-arrestin-biased ligands of μ-opioid receptors: Prevention of antinociceptive tolerance.
    Mori T; Kuzumaki N; Arima T; Narita M; Tateishi R; Kondo T; Hamada Y; Kuwata H; Kawata M; Yamazaki M; Sugita K; Matsuzawa A; Baba K; Yamauchi T; Higashiyama K; Nonaka M; Miyano K; Uezono Y; Narita M
    Mol Pain; 2017; 13():1744806917740030. PubMed ID: 29056067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, Synthesis, and Biological Evaluation of Bivalent Ligands Targeting Dopamine D
    Qian M; Vasudevan L; Huysentruyt J; Risseeuw MDP; Stove C; Vanderheyden PML; Van Craenenbroeck K; Van Calenbergh S
    ChemMedChem; 2018 May; 13(9):944-956. PubMed ID: 29451744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Steric interactions and the activity of fentanyl analogs at the mu-opioid receptor.
    Dosen-Micovic L; Ivanovic M; Micovic V
    Bioorg Med Chem; 2006 May; 14(9):2887-95. PubMed ID: 16376082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The mechanism of ligand-induced activation or inhibition of μ- and κ-opioid receptors.
    Yuan S; Palczewski K; Peng Q; Kolinski M; Vogel H; Filipek S
    Angew Chem Int Ed Engl; 2015 Jun; 54(26):7560-3. PubMed ID: 25968837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carfentanil is a β-arrestin-biased agonist at the μ opioid receptor.
    Ramos-Gonzalez N; Groom S; Sutcliffe KJ; Bancroft S; Bailey CP; Sessions RB; Henderson G; Kelly E
    Br J Pharmacol; 2023 Sep; 180(18):2341-2360. PubMed ID: 37005796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding mode analyses of NAP derivatives as mu opioid receptor selective ligands through docking studies and molecular dynamics simulation.
    Wang H; Zaidi SA; Zhang Y
    Bioorg Med Chem; 2017 Apr; 25(8):2463-2471. PubMed ID: 28302509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction of p-fluorofentanyl on cloned human opioid receptors and exploration of the role of Trp-318 and His-319 in mu-opioid receptor selectivity.
    Ulens C; Van Boven M; Daenens P; Tytgat J
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1024-33. PubMed ID: 10945855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stereochemical requirements for pseudoirreversible inhibition of opioid mu receptor binding by the 3-methylfentanyl congeners, RTI-46144 and its enantiomers: evidence for different binding domains.
    Ni Q; Xu H; Partilla JS; Stark PA; Carroll FI; Brine GA; Rothman RB
    Synapse; 1993 Dec; 15(4):296-306. PubMed ID: 8153877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and Evaluation of Novel Biased μ-Opioid-Receptor (μOR) Agonists.
    Ma M; Sun J; Li M; Yu Z; Cheng J; Zhong B; Shi W
    Molecules; 2019 Jan; 24(2):. PubMed ID: 30641969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A constitutively internalizing and recycling mutant of the mu-opioid receptor.
    Segredo V; Burford NT; Lameh J; Sadée W
    J Neurochem; 1997 Jun; 68(6):2395-404. PubMed ID: 9166733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An opioid agonist that does not induce mu-opioid receptor--arrestin interactions or receptor internalization.
    Groer CE; Tidgewell K; Moyer RA; Harding WW; Rothman RB; Prisinzano TE; Bohn LM
    Mol Pharmacol; 2007 Feb; 71(2):549-57. PubMed ID: 17090705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reanalysis of a μ opioid receptor crystal structure reveals a covalent adduct with BU72.
    Munro TA
    BMC Biol; 2023 Oct; 21(1):213. PubMed ID: 37817141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct domains of the mu-opioid receptor control uncoupling and internalization.
    Celver J; Xu M; Jin W; Lowe J; Chavkin C
    Mol Pharmacol; 2004 Mar; 65(3):528-37. PubMed ID: 14978231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness comparisons of G-protein biased and unbiased mu opioid receptor ligands in warm water tail-withdrawal and drug discrimination in male and female rats.
    Schwienteck KL; Faunce KE; Rice KC; Obeng S; Zhang Y; Blough BE; Grim TW; Negus SS; Banks ML
    Neuropharmacology; 2019 May; 150():200-209. PubMed ID: 30660628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Photopharmacology of Ion Channels through the Light of the Computational Microscope.
    Nin-Hill A; Mueller NPF; Molteni C; Rovira C; Alfonso-Prieto M
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.